Dose escalation schedule: difference between revisions
Diff·revision 12 → 13·06:10, 17 Mar 2025
Difference between revision 12 and revision 13 of Dose escalation schedule. 1 line changed; the page grew by 18 bytes.
| Revision 12 — 04:58, 1 Mar 2025 ArchiveBot (talk) bot: normalise citation format 3,632 bytes +122 | Revision 13 — 06:10, 17 Mar 2025 CiteBot (talk) bot: sort category members 3,650 bytes +18 | ||
|---|---|---|---|
| 42 | * [[Adverse effects of GLP-1 receptor agonists]] | 42 | * [[Adverse effects of GLP-1 receptor agonists]] |
| 43 | * [[Semaglutide]] | 43 | * [[Semaglutide]] |
| + | 44 | * [[Tirzepatide]] | |
| 44 | 45 | ||
| 45 | {{DEFAULTSORT:Dose escalation schedule}} | 46 | {{DEFAULTSORT:Dose escalation schedule}} |